Gideon Korrell on the Federal Circuit’s Janssen Decision

In July 2025, the Federal Circuit delivered an important ruling in Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. The case centered on U.S. Patent No. 9,439,906, which protects specific dosing regimens for long-acting injectable form...